Mounjaro® KwikPen (Tirzepatide)
Price range: $192.00 through $395.00
Mounjaro® KwikPen contains tirzepatide, an innovative once-weekly injectable treatment designed to support weight management in eligible adults. Tirzepatide works by targeting both GLP-1 and GIP receptors, helping to regulate appetite, reduce food cravings, and increase feelings of fullness after meals.
Description
Mounjaro® KwikPen (Tirzepatide)
Advanced Weekly Weight Management Support with Tirzepatide
Mounjaro® KwikPen contains tirzepatide, an innovative once-weekly injectable treatment designed to support weight management in eligible adults. Tirzepatide works by targeting both GLP-1 and GIP receptors, helping to regulate appetite, reduce food cravings, and increase feelings of fullness after meals.
By supporting appetite control and healthier eating habits, Mounjaro® can help individuals achieve meaningful and sustainable weight management results when combined with a balanced diet and regular physical activity.
Why Choose Mounjaro®?
- Once-weekly self-administered injection
- Contains tirzepatide, a dual GIP and GLP-1 receptor agonist
- Helps reduce hunger and food cravings
- Supports portion control and appetite management
- Convenient KwikPen® delivery system
- Available in multiple dosage strengths
- Designed to support long-term weight management goals
How Mounjaro® Works
Mounjaro® contains tirzepatide, which activates both GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors. These naturally occurring hormones play an important role in appetite regulation, metabolism, and feelings of satiety.
By enhancing the body’s natural hormonal responses, Mounjaro® helps users feel fuller for longer, reduce calorie intake, and maintain better control over eating habits throughout the day.
Weight Management Benefits
- Supports appetite regulation
- Helps reduce food cravings
- Promotes feelings of fullness after meals
- Supports body weight management when used alongside lifestyle changes
- Convenient once-weekly dosing schedule
Who May Be Eligible?
Mounjaro® may be suitable for adults who:
- Have a Body Mass Index (BMI) of 30 kg/m² or above, or
- Have a BMI of 27 kg/m² or above with a weight-related health condition or risk factor
Eligibility requirements may vary and should be assessed by a qualified healthcare professional.
Available Strengths
Mounjaro® KwikPen is available in multiple strengths, including:
- 2.5mg
- 5mg
- 7.5mg
- 10mg
- 12.5mg
- 15mg
Product Information
- Brand: Mounjaro®
- Active Ingredient: Tirzepatide
- Product Type: Pre-filled Injection Pen
- Administration: Subcutaneous Injection
- Dosing Schedule: Once Weekly
- Category: Weight Management
- Manufacturer: Eli Lilly
Important Information
Mounjaro® should be used as part of a comprehensive weight management program that includes dietary changes, physical activity, and ongoing lifestyle support. Always follow the instructions provided with your treatment plan and consult a healthcare professional regarding suitability and use.
Additional information
| Dose | 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg |
|---|










Reviews
There are no reviews yet.